Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Sep 16, 2022

SELL
$42.05 - $47.77 $230,391 - $261,731
-5,479 Reduced 42.29%
7,476 $325,000
Q1 2022

Apr 12, 2022

SELL
$40.23 - $47.74 $165,787 - $196,736
-4,121 Reduced 24.13%
12,955 $575,000
Q4 2021

Jan 10, 2022

BUY
$38.88 - $45.31 $67,690 - $78,884
1,741 Added 11.35%
17,076 $767,000
Q3 2021

Oct 06, 2021

SELL
$38.79 - $43.16 $60,589 - $67,415
-1,562 Reduced 9.24%
15,335 $597,000
Q2 2021

Jul 07, 2021

SELL
$36.52 - $41.46 $27,791 - $31,551
-761 Reduced 4.31%
16,897 $686,000
Q1 2021

Apr 06, 2021

BUY
$34.27 - $40.01 $41,946 - $48,972
1,224 Added 7.45%
17,658 $642,000
Q4 2020

Jan 05, 2021

SELL
$34.07 - $39.94 $17,954 - $21,048
-527 Reduced 3.11%
16,434 $616,000
Q3 2020

Oct 01, 2020

BUY
$38.11 - $42.99 $263,073 - $296,759
6,903 Added 68.63%
16,961 $650,000
Q2 2020

Jul 07, 2020

BUY
$37.87 - $43.58 $32,189 - $37,043
850 Added 9.23%
10,058 $418,000
Q1 2020

Apr 07, 2020

SELL
$32.47 - $48.83 $1,591 - $2,392
-49 Reduced 0.53%
9,208 $355,000
Q3 2019

Oct 01, 2019

BUY
$40.46 - $43.52 $768 - $826
19 Added 0.21%
9,257 $402,000
Q2 2019

Jul 02, 2019

BUY
$39.4 - $42.7 $82,897 - $89,840
2,104 Added 29.49%
9,238 $0
Q1 2019

Apr 02, 2019

BUY
$38.57 - $42.69 $7,714 - $8,538
200 Added 2.88%
7,134 $0
Q4 2018

Jan 03, 2019

BUY
$37.8 - $42.69 $2,872 - $3,244
76 Added 1.11%
6,934 $270,000
Q3 2018

Oct 09, 2018

BUY
$39.75 - $42.69 $32,118 - $34,493
808 Added 13.36%
6,858 $0
Q2 2018

Jul 03, 2018

SELL
$39.61 - $42.76 $21,310 - $23,004
-538 Reduced 8.17%
6,050 $0
Q1 2018

Apr 03, 2018

SELL
$36.18 - $40.15 $16,425 - $18,228
-454 Reduced 6.45%
6,588 $0
Q4 2017

Jan 16, 2018

SELL
$35.34 - $41.9 $32,018 - $37,961
-906 Reduced 11.4%
7,042 $0
Q3 2017

Oct 12, 2017

BUY
$39.44 - $41.55 $313,469 - $330,239
7,948
7,948 $0

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Private Trust CO Na Portfolio

Follow Private Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Private Trust CO Na with notifications on news.